Trials / Completed
CompletedNCT00395473
Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)
Ezetimibe Added to Statin Therapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 141 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In the context of australian general practice, to determine the efficacy and safety of ezetimibe 10mg/statin 40mg coadministration in patients with uncontrolled cholesterol receiving statin 40mg or more.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0653, ezetimibe / Duration of Treatment: 6 Weeks |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2006-11-03
- Last updated
- 2024-05-10
Source: ClinicalTrials.gov record NCT00395473. Inclusion in this directory is not an endorsement.